Treatment of Seborrheic Dermatitis
The first-line treatment for seborrheic dermatitis is topical ketoconazole 2% cream applied twice daily for four weeks, with antifungal shampoos for scalp involvement and short-term topical corticosteroids for inflammation. 1, 2
First-Line Treatment Options
For Facial and Body Involvement:
- Topical antifungals:
For Scalp Involvement:
- Antifungal shampoos:
Treatment Algorithm
Initial Assessment:
- Identify affected areas (scalp, face, chest, back, axilla, groin)
- Assess severity (mild, moderate, severe)
Treatment by Location:
For Moderate to Severe Cases:
Maintenance Phase:
Comparative Efficacy
Ketoconazole 2% cream has shown comparable efficacy to 1% hydrocortisone cream in treating seborrheic dermatitis:
- In a double-blind trial, ketoconazole 2% cream resulted in 81.6% symptomatic improvement compared to 87.2% with hydrocortisone 1% cream 7
- Ketoconazole significantly reduces Malassezia (P. ovale) yeast counts, which is believed to play a key role in the pathogenesis of seborrheic dermatitis 3
Prevention of Relapse
For patients who respond to initial treatment:
- Weekly application of ketoconazole 2% shampoo significantly reduces relapse rates (19%) compared to placebo (47%) 3
- Proactive maintenance therapy with twice-weekly application of topical treatments to previously affected areas can help prevent relapse 6
Important Considerations and Pitfalls
- Avoid prolonged use of potent topical corticosteroids, especially on the face, to prevent skin atrophy and other adverse effects 6
- Reassess diagnosis if no improvement after four weeks of treatment 1
- Identify and eliminate triggers where possible 6
- Avoid long-term use of topical antibiotics due to risk of resistance and sensitization 6
- For severe or recalcitrant cases, consider referral to a dermatologist for alternative treatments such as calcineurin inhibitors or phototherapy 6, 8
Special Populations
- Infants with cradle cap: Gentle shampooing with mild baby shampoo and soft brushing to remove scales; ketoconazole shampoo may be used if standard measures fail
- Immunocompromised patients: May require more aggressive or prolonged therapy due to higher risk of severe or recalcitrant disease